APO RESEARCH · REPORT
Artificial Intelligence Health Risk Management Platform
Selected research
Market Outlook & Growth Opportunities
Global Artificial Intelligence Health Risk Management Platform Market Outlook and Growth Opportunities 2026
Market perspective
The global Artificial Intelligence Health Risk Management Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Artificial Intelligence Health Risk Management Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Artificial Intelligence Health Risk Management Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Artificial Intelligence Health Risk Management Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Artificial Intelligence Health Risk Management Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Artificial Intelligence Health Risk Management Platform market include IBM, Health Catalyst, Verisk, Evolent, Optum, Ayasdi, Cleerly and Health at Scale, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Artificial Intelligence Health Risk Management Platform market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Artificial Intelligence Health Risk Management Platform and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Artificial Intelligence Health Risk Management Platform revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Artificial Intelligence Health Risk Management Platform market.
Artificial Intelligence Health Risk Management Platform Segment by Company
IBM
Health Catalyst
Verisk
Evolent
Optum
Ayasdi
Cleerly
Health at Scale
Artificial Intelligence Health Risk Management Platform Segment by Type
Cloud-Based
On-Premises
Artificial Intelligence Health Risk Management Platform Segment by Application
Adults
Children
Artificial Intelligence Health Risk Management Platform Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Artificial Intelligence Health Risk Management Platform status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Artificial Intelligence Health Risk Management Platform key companies, revenue, market share, and recent developments.
3. To split the Artificial Intelligence Health Risk Management Platform breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Artificial Intelligence Health Risk Management Platform market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Artificial Intelligence Health Risk Management Platform significant trends, drivers, influence factors in global and regions.
6. To analyze Artificial Intelligence Health Risk Management Platform competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Intelligence Health Risk Management Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artificial Intelligence Health Risk Management Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Intelligence Health Risk Management Platform.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Artificial Intelligence Health Risk Management Platform industry.
Chapter 3: Detailed analysis of Artificial Intelligence Health Risk Management Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Artificial Intelligence Health Risk Management Platform in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Artificial Intelligence Health Risk Management Platform in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Cloud-Based
- On-Premises
Applications
- Adults
- Children
Companies covered
- IBM
- Health Catalyst
- Verisk
- Evolent
- Optum
- Ayasdi
- Cleerly
- Health at Scale
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Artificial Intelligence Health Risk Management Platform Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Artificial Intelligence Health Risk Management Platform Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Artificial Intelligence Health Risk Management Platform Market Dynamics
- 2.1 Artificial Intelligence Health Risk Management Platform Industry Trends
- 2.2 Artificial Intelligence Health Risk Management Platform Industry Drivers
- 2.3 Artificial Intelligence Health Risk Management Platform Industry Opportunities and Challenges
- 2.4 Artificial Intelligence Health Risk Management Platform Industry Restraints
3 Artificial Intelligence Health Risk Management Platform Market by Company
- 3.1 Global Artificial Intelligence Health Risk Management Platform Company Revenue Ranking in 2025
- 3.2 Global Artificial Intelligence Health Risk Management Platform Revenue by Company (2021-2026)
- 3.3 Global Artificial Intelligence Health Risk Management Platform Company Ranking (2024-2026)
- 3.4 Global Artificial Intelligence Health Risk Management Platform Company Manufacturing Base and Headquarters
- 3.5 Global Artificial Intelligence Health Risk Management Platform Company Product Type and Application
- 3.6 Global Artificial Intelligence Health Risk Management Platform Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Artificial Intelligence Health Risk Management Platform Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Artificial Intelligence Health Risk Management Platform Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Artificial Intelligence Health Risk Management Platform Market by Type
- 4.1 Artificial Intelligence Health Risk Management Platform Type Introduction
- 4.1.1 Cloud-Based
- 4.1.2 On-Premises
- 4.2 Global Artificial Intelligence Health Risk Management Platform Sales Value by Type
- 4.2.1 Global Artificial Intelligence Health Risk Management Platform Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Artificial Intelligence Health Risk Management Platform Sales Value by Type (2021-2032)
- 4.2.3 Global Artificial Intelligence Health Risk Management Platform Sales Value Share by Type (2021-2032)
5 Artificial Intelligence Health Risk Management Platform Market by Application
- 5.1 Artificial Intelligence Health Risk Management Platform Application Introduction
- 5.1.1 Adults
- 5.1.2 Children
- 5.2 Global Artificial Intelligence Health Risk Management Platform Sales Value by Application
- 5.2.1 Global Artificial Intelligence Health Risk Management Platform Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Artificial Intelligence Health Risk Management Platform Sales Value by Application (2021-2032)
- 5.2.3 Global Artificial Intelligence Health Risk Management Platform Sales Value Share by Application (2021-2032)
6 Artificial Intelligence Health Risk Management Platform Regional Value Analysis
- 6.1 Global Artificial Intelligence Health Risk Management Platform Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Artificial Intelligence Health Risk Management Platform Sales Value by Region (2021-2032)
- 6.2.1 Global Artificial Intelligence Health Risk Management Platform Sales Value by Region: 2021-2026
- 6.2.2 Global Artificial Intelligence Health Risk Management Platform Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Artificial Intelligence Health Risk Management Platform Sales Value (2021-2032)
- 6.3.2 North America Artificial Intelligence Health Risk Management Platform Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Artificial Intelligence Health Risk Management Platform Sales Value (2021-2032)
- 6.4.2 Europe Artificial Intelligence Health Risk Management Platform Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Artificial Intelligence Health Risk Management Platform Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Artificial Intelligence Health Risk Management Platform Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Artificial Intelligence Health Risk Management Platform Sales Value (2021-2032)
- 6.6.2 South America Artificial Intelligence Health Risk Management Platform Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Artificial Intelligence Health Risk Management Platform Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Artificial Intelligence Health Risk Management Platform Sales Value Share by Country, 2025 VS 2032
7 Artificial Intelligence Health Risk Management Platform Country-level Value Analysis
- 7.1 Global Artificial Intelligence Health Risk Management Platform Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Artificial Intelligence Health Risk Management Platform Sales Value by Country (2021-2032)
- 7.2.1 Global Artificial Intelligence Health Risk Management Platform Sales Value by Country (2021-2026)
- 7.2.2 Global Artificial Intelligence Health Risk Management Platform Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Artificial Intelligence Health Risk Management Platform Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Artificial Intelligence Health Risk Management Platform Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Artificial Intelligence Health Risk Management Platform Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Artificial Intelligence Health Risk Management Platform Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Artificial Intelligence Health Risk Management Platform Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Artificial Intelligence Health Risk Management Platform Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Artificial Intelligence Health Risk Management Platform Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Artificial Intelligence Health Risk Management Platform Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Artificial Intelligence Health Risk Management Platform Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Artificial Intelligence Health Risk Management Platform Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Artificial Intelligence Health Risk Management Platform Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Artificial Intelligence Health Risk Management Platform Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Artificial Intelligence Health Risk Management Platform Sales Value Growth Rate (2021-2032)
- 7.7.2 France Artificial Intelligence Health Risk Management Platform Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Artificial Intelligence Health Risk Management Platform Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Artificial Intelligence Health Risk Management Platform Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Artificial Intelligence Health Risk Management Platform Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Artificial Intelligence Health Risk Management Platform Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Artificial Intelligence Health Risk Management Platform Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Artificial Intelligence Health Risk Management Platform Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Artificial Intelligence Health Risk Management Platform Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Artificial Intelligence Health Risk Management Platform Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Artificial Intelligence Health Risk Management Platform Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Artificial Intelligence Health Risk Management Platform Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Artificial Intelligence Health Risk Management Platform Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Artificial Intelligence Health Risk Management Platform Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Artificial Intelligence Health Risk Management Platform Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Artificial Intelligence Health Risk Management Platform Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Artificial Intelligence Health Risk Management Platform Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Artificial Intelligence Health Risk Management Platform Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Artificial Intelligence Health Risk Management Platform Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Artificial Intelligence Health Risk Management Platform Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Artificial Intelligence Health Risk Management Platform Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Artificial Intelligence Health Risk Management Platform Sales Value Growth Rate (2021-2032)
- 7.14.2 China Artificial Intelligence Health Risk Management Platform Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Artificial Intelligence Health Risk Management Platform Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Artificial Intelligence Health Risk Management Platform Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Artificial Intelligence Health Risk Management Platform Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Artificial Intelligence Health Risk Management Platform Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Artificial Intelligence Health Risk Management Platform Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Artificial Intelligence Health Risk Management Platform Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Artificial Intelligence Health Risk Management Platform Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Artificial Intelligence Health Risk Management Platform Sales Value Growth Rate (2021-2032)
- 7.17.2 India Artificial Intelligence Health Risk Management Platform Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Artificial Intelligence Health Risk Management Platform Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Artificial Intelligence Health Risk Management Platform Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Artificial Intelligence Health Risk Management Platform Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Artificial Intelligence Health Risk Management Platform Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Artificial Intelligence Health Risk Management Platform Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Artificial Intelligence Health Risk Management Platform Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Artificial Intelligence Health Risk Management Platform Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Artificial Intelligence Health Risk Management Platform Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Artificial Intelligence Health Risk Management Platform Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Artificial Intelligence Health Risk Management Platform Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Artificial Intelligence Health Risk Management Platform Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Artificial Intelligence Health Risk Management Platform Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Artificial Intelligence Health Risk Management Platform Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Artificial Intelligence Health Risk Management Platform Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Artificial Intelligence Health Risk Management Platform Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Artificial Intelligence Health Risk Management Platform Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Artificial Intelligence Health Risk Management Platform Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Artificial Intelligence Health Risk Management Platform Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Artificial Intelligence Health Risk Management Platform Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Artificial Intelligence Health Risk Management Platform Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Artificial Intelligence Health Risk Management Platform Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Artificial Intelligence Health Risk Management Platform Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Artificial Intelligence Health Risk Management Platform Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Artificial Intelligence Health Risk Management Platform Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Artificial Intelligence Health Risk Management Platform Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Artificial Intelligence Health Risk Management Platform Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Artificial Intelligence Health Risk Management Platform Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Artificial Intelligence Health Risk Management Platform Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Artificial Intelligence Health Risk Management Platform Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Artificial Intelligence Health Risk Management Platform Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Artificial Intelligence Health Risk Management Platform Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Artificial Intelligence Health Risk Management Platform Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Artificial Intelligence Health Risk Management Platform Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Artificial Intelligence Health Risk Management Platform Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Artificial Intelligence Health Risk Management Platform Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Artificial Intelligence Health Risk Management Platform Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Artificial Intelligence Health Risk Management Platform Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Artificial Intelligence Health Risk Management Platform Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Artificial Intelligence Health Risk Management Platform Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Artificial Intelligence Health Risk Management Platform Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 IBM
- 8.1.1 IBM Company Information
- 8.1.2 IBM Business Overview
- 8.1.3 IBM Artificial Intelligence Health Risk Management Platform Revenue and Gross Margin (2021-2026)
- 8.1.4 IBM Artificial Intelligence Health Risk Management Platform Product Portfolio
- 8.1.5 IBM Recent Developments
- 8.2 Health Catalyst
- 8.2.1 Health Catalyst Company Information
- 8.2.2 Health Catalyst Business Overview
- 8.2.3 Health Catalyst Artificial Intelligence Health Risk Management Platform Revenue and Gross Margin (2021-2026)
- 8.2.4 Health Catalyst Artificial Intelligence Health Risk Management Platform Product Portfolio
- 8.2.5 Health Catalyst Recent Developments
- 8.3 Verisk
- 8.3.1 Verisk Company Information
- 8.3.2 Verisk Business Overview
- 8.3.3 Verisk Artificial Intelligence Health Risk Management Platform Revenue and Gross Margin (2021-2026)
- 8.3.4 Verisk Artificial Intelligence Health Risk Management Platform Product Portfolio
- 8.3.5 Verisk Recent Developments
- 8.4 Evolent
- 8.4.1 Evolent Company Information
- 8.4.2 Evolent Business Overview
- 8.4.3 Evolent Artificial Intelligence Health Risk Management Platform Revenue and Gross Margin (2021-2026)
- 8.4.4 Evolent Artificial Intelligence Health Risk Management Platform Product Portfolio
- 8.4.5 Evolent Recent Developments
- 8.5 Optum
- 8.5.1 Optum Company Information
- 8.5.2 Optum Business Overview
- 8.5.3 Optum Artificial Intelligence Health Risk Management Platform Revenue and Gross Margin (2021-2026)
- 8.5.4 Optum Artificial Intelligence Health Risk Management Platform Product Portfolio
- 8.5.5 Optum Recent Developments
- 8.6 Ayasdi
- 8.6.1 Ayasdi Company Information
- 8.6.2 Ayasdi Business Overview
- 8.6.3 Ayasdi Artificial Intelligence Health Risk Management Platform Revenue and Gross Margin (2021-2026)
- 8.6.4 Ayasdi Artificial Intelligence Health Risk Management Platform Product Portfolio
- 8.6.5 Ayasdi Recent Developments
- 8.7 Cleerly
- 8.7.1 Cleerly Company Information
- 8.7.2 Cleerly Business Overview
- 8.7.3 Cleerly Artificial Intelligence Health Risk Management Platform Revenue and Gross Margin (2021-2026)
- 8.7.4 Cleerly Artificial Intelligence Health Risk Management Platform Product Portfolio
- 8.7.5 Cleerly Recent Developments
- 8.8 Health at Scale
- 8.8.1 Health at Scale Company Information
- 8.8.2 Health at Scale Business Overview
- 8.8.3 Health at Scale Artificial Intelligence Health Risk Management Platform Revenue and Gross Margin (2021-2026)
- 8.8.4 Health at Scale Artificial Intelligence Health Risk Management Platform Product Portfolio
- 8.8.5 Health at Scale Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst